Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Region    |    News By Date    |    Business Directory
All Press Releases for April 18, 2007 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



NUTRITIONAL SUPPLEMENTS SAFE AND BENEFICIAL FOR PATIENTS UNDERGOING CHEMOTHERAPY AND RADIATION THERAPY Contrary to Popular Belief, Supplements Enhance Treatment and Increase Survival
x-small text small text medium text large text


    /24-7PressRelease/ - April 18, 2007 - NEWPORT BEACH, CA — April 16, 2007 — For nearly a decade, oncologists have been telling patients undergoing chemotherapy or radiation therapy that they should not take antioxidants and other nutritional supplements because they interfere with treatment. However, a two-part article published in the most recent issues of Alternative Therapies, should lay this myth to rest.

Oncologist Charles B. Simone, MD, and colleagues searched MEDLINE (the National Library of Medicine's database of more than 16 million medical journals dating back to the 1950s), and CANCERLIT (the National Cancer Institute's database of articles related to cancer) and came up with 280 peer-reviewed studies on the concurrent use of chemo and/or radiation and dietary supplements. These included 50 human studies involving a total of 8,251 patients.

They found that antioxidants and other nutritional supplements did not interfere with conventional cancer treatments and actually enhanced the killing effects of chemotherapy and radiation therapy. In 47 of the human studies, supplements were also found to protect normal tissues and reduce the often-serious side effects of chemotherapy and radiation. And in 15 human studies, 3,738 patients actually had increased survival - a finding that is rare for any cancer outcome.

Dr. Simone reports that the negative slant on supplements originated from an erroneous statement made in a 1997 New York Times by a physician from Memorial Sloan Kettering Cancer Hospital, who contended that vitamin C interfered with chemotherapy and radiation in humans. This statement had absolutely no scientific backing, yet without even reviewing the evidence, the entire oncology community adopted and continues to spread this harmful, biased misconception.

There is no downside to taking supplements while undergoing chemotherapy, but there is a tremendous upside. The immune systems of cancer patients are highly compromised, and a majority of them suffer with malnutrition. Antioxidants and other vitamins and
minerals restore deficiencies in essential nutrients and enhance immune function. Furthermore, antioxidants have direct anti-tumor effects, protect against the toxic effects of conventional cancer treatments, and prolong the lives of patients.

# # #

If you'd like more information on this topic, or to schedule an interview with Charles B. Simone, MD, please call (609) 896-2646 or email Dr. Simone at mail@drsimone.com


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #

Press Release Keywords:
Other Press Release Headlines:

Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Social Media:
Share or bookmark this story using Facebook, Twitter, Digg, and more.

Bookmark and Share
Press Release Contact Information:
Lorena Barragan
Freedom of Health Foundation

MD
4321 Birch St
Newport Beach, Ca
US 92660
Voice: 714-619-1600
Fax: 714-636-3241
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.